LH - Labcorp Holdings Inc. Forward P/S Multiple

Corporate emblem and logo of Labcorp Holdings (LH)

Labcorp Holdings Inc. (LH) is a strategic ally to global pharma behemoths, integrating diagnostics into medical networks. The issuer's forward P/S, as reflected in this GURU.Markets chart, shows that the value of 1.30 aligns with the current metric. Growth is supported by the implementation of AI diagnostics and genomics, although wage inflation and government regulation of tariffs create certain risks for profits.

LH Labcorp: Market Cap to Future Revenue Ratio in the range 07/04/2022 - 11/13/2026

Financial and market metric breakdowns for LabCorp (LH)

- current price and projected stock value:
Stock Price Labcorp|LH - Price Target Chart
- market capitalization statistics:
Market Capitalization LabCorp|LH - Real Price to Acquire Entire Company
- issuer book value statistics:
Net Assets per Single Share Labcorp|LH - Total Stockholders' Equity|Market Value to Book Value Ratio labcorp.com|LH - Aggregate Asset Value
- debt level and financial liquidity data:
Debt to Equity Labcorp Holdings Inc.|LH - Long-Term Liabilities to Equity|Short-Term Debt to Equity Ratio Labcorp Holdings Inc.|LH - Aggregate Debt Obligations|Debts to Book Capitalization LabCorp|LH - Company Long-Term Loans and Borrowings|Company Short-Term Debt Labcorp|Quick Liquidity labcorp.com
- business earnings and investment ratios data:
LH - Company Net Income|Projected Future Earnings Labcorp Holdings Inc.|LH - Price to Earnings Multiple|Forward P/E Multiple Laboratory Corporation of America|LH - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization LabCorp|LH - Operating profit before amortization|Net earnings per share (EPS TTM) Labcorp|LH - Net earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months labcorp.com|LH - Expected net earnings per share growth this year|Expected earnings per share growth for next year Labcorp Holdings Inc.
- revenue and sales details:
LH - Company Sales Revenue|Projected Sales Volume Labcorp|LH - Price-to-Revenue Coefficient|Price-to-Projected Revenue Ratio LabCorp
Summary company analysis:Labcorp LH
Original product of labcorp.com

For Labcorp Holdings Inc. (LH), whose dominance is secured by large-scale logistics and IT integration, the forward P/S serves as an indicator of the market value of one dollar of expected revenue. The ratio of market capitalization to projected sales volume, reflected by the current forward P/S level, allows for an assessment of whether the premium for pricing power is justified. The stability of this multiple confirms the fundamental resilience of the business and the insurmountable barriers to entry for competitors.

Key competitors

Forward P/S Multiple IQV (IQVIA)|Medpace Holdings - Price-to-Projected Revenue Ratio|ICON Corp - Forward P/S Multiple|Charles River Corp (CRL) - Forward Price-to-Revenue Multiple|Evotec SE (EVO) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio fortrea.com (FTRE)|Price-to-Projected Revenue Ratio Lifecore Biomedical Inc.|OABI: Forward Price to Sales|Price-to-Projected Revenue Ratio Inotiv Corp (NOTV)|CDMO: Future Price to Revenue|Catalent, Inc. - Forward Price-to-Revenue Multiple|Forward Price to Sales SCPX